Vastus lateralis fiber shift is an independent predictor of mortality in chronic obstructive pulmonary disease

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 3, 2014, Pages 350-352

  Patel, Mehul S ^a   Natanek, Samantha A ^b   Stratakos, Grigorios ^c   Pascual, Sergi ^d   Martínez Llorens, Juana ^d   Disano, Laura ^a   Terzis, Gerasimos ^c   Hopkinson, Nicholas S ^b   Gea, Joaquim ^d   Vogiatzis, Ioannis ^c   Maltais, François ^e   Polkey, Michael I ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF ATHENS   (Greece)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; EXERCISE TOLERANCE; FAT FREE MASS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE GRAFT; PRIORITY JOURNAL; PROGNOSIS; RESIDUAL VOLUME; RETROSPECTIVE STUDY; TOTAL LUNG CAPACITY; VASTUS LATERALIS FIBER SHIFT; AGE DISTRIBUTION; FAST MUSCLE FIBER; MULTICENTER STUDY (TOPIC); PATHOLOGY; PATHOPHYSIOLOGY; QUADRICEPS FEMORIS MUSCLE; SLOW MUSCLE FIBER;

AGE DISTRIBUTION; AGED; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MULTICENTER STUDIES AS TOPIC; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; RETROSPECTIVE STUDIES;

EID: 84907291502     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201404-0713LE     Document Type: Letter

References (14)

1. Seymour JM, Spruit MA, Hopkinson NS, Natanek SA, Man WD, Jackson A, Gosker HR, Schols AM, Moxham J, Polkey MI, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 2010;36:81-88.
2. Shrikrishna D, Patel M, Tanner RJ, Seymour JM, Connolly BA, Puthucheary ZA, Walsh SL, Bloch SA, Sidhu PS, Hart N, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J 2012;40:1115-1122.
3. Natanek SA, Gosker HR, Slot IG, Marsh GS, Hopkinson NS, Man WD, Tal-Singer R, Moxham J, Kemp PR, Schols AM, et al. Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (COPD); implications for stratified medicine? Muscle Nerve 2013;48:488-497.
4. Vogiatzis I, Simoes DC, Stratakos G, Kourepini E, Terzis G, Manta P, Athanasopoulos D, Roussos C, Wagner PD, Zakynthinos S. Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD. Eur Respir J 2010;36:301-310.
5. Marquis K, Debigaré R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, Maltais F. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:809-813.
6. Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, Cetti EJ, Moore AJ, Moxham J, Polkey MI. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007;62:115-120.
7. Patel MS, Natanek SA, Shrikrisha D, Gea J, Terzis J, Hopkinson NS, Vogiatzis I, Maltais F, Polkey MI. Vastus lateralis fiber shift is predictive of mortality in COPD [abstract]. Am J Respir Crit Care Med 2014;189:A3646.
8. Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, Bruijnzeel PL, Rutten EP, Op 't Roodt J, Wouters EF, Franssen FM. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187:728-735.
9. OgaT,NishimuraK,TsukinoM,SatoS,HajiroT.Analysisof thefactorsrelated to mortality in chronic obstructive pulmonary disease: role of exercise capacityandhealthstatus.AmJRespirCritCareMed2003;167:544-549.
10. Patel MS, Mohan D, Andersson YM, Baz M, Kon SS, Canavan JL, Jackson SG, Clark AL, Hopkinson NS, Natanek SA, et al. Phenotypic characteristics associated with reduced short physical performance battery score in chronic obstructive pulmonary disease. Chest 2014;145:1016-1024.
11. Waschki B, Kirsten A, Holz O, Müller KC, Meyer T, Watz H, Magnussen H. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011;140:331-342.
12. Guillot C, Steinberg JG, Delliaux S, Kipson N, Jammes Y, Badier M. Physiological, histological and biochemical properties of rat skeletal muscles in response to hindlimb suspension. J Electromyogr Kinesiol 2008;18:276-283.
13. Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H, Evans RM. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2004;2:e294.
14. Steiner MC, Roubenoff R, Tal-Singer R, Polkey MI. Prospects for the development of effective pharmacotherapy targeted at the skeletal muscles in chronic obstructive pulmonary disease: a translational review. Thorax 2012;67:1102-1109.